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Abstract 
Introduction: Staphylococcus aureus is known to be a major cause of skin and soft tissue infections, pneumonia and invasive diseases. In this 
study, attempts were made to examine the prevalence of tsst-1, eta, etb, and luk-PV genes among methicillin-resistant S. aureus (MRSA) 
isolated from children in Tehran. 
Methodology: In the present cross-sectional study, a total of 100 MRSA were isolated from children who were referred to a pediatric hospital 
during 11-month period of September 2014 to August 2015. Isolates were identified using biochemical tests and then, using PCR, the isolates 
were tested for the presence of mecA, tsst-1, eta, etb, and luk-PV genes. Susceptibility of isolates to cefoxitin, penicillin, erythromycin, 
clindamycin, gentamicin, rifampin, minocycline, co-trimoxazole, linezolid, and vancomycin were evaluated using standard methods. 
Results: It was found that the MRSA isolates had the greatest resistance to clindamycin (72%) and erythromycin (59%), while the lowest 
rates of resistance were observed to be related to minocycline (6%) and rifampin (12%). All of isolates were sensitive to vancomycin and 
linezolid. The mecA gene was detected in all the isolates. Moreover, luk-PV and tsst-1 were detected in 18% and 17% of the isolates, 
respectively. None of the isolates harbored eta and etb genes. 
Conclusions: Our data provide specifications about the toxin production status of S. aureus isolates from pediatric children. The current study 
showed increased resistance to different antibiotics in S. aureus isolates. Therefore, to prevent multi-resistance to other antibiotic classes, it is 
essential to withhold prescriptions and stop unessential use of available antibiotics. 
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Introduction 
Although Staphylococcus aureus normally 
colonizes the nares and skin in up to 80% of the 
population, it poses as one of the most important 
bacterial pathogens that cause a wide variety of diseases 
in humans. It has long been considered as not only the 
leading cause of community-acquired skin and soft 
tissue infections, but also one of the most important 
organisms causing life-threatening nosocomial 
infections, including necrotizing pneumonia, 
bacteremia, and various surgical wound infections 
[1,2]. Meanwhile, neonates and young children are 
more susceptible to serious complications of S. aureus, 
particularly skin infections [3]. 
Pathogenicity of S. aureus is mainly related to the 
repertoire virulence factors including toxins, invasive 
capacity, adhesins, exoenzymes, and immune-
modulating proteins it produces as well as a variety of 
resistance mechanisms to many existing antibiotics. 
The most important virulence factors with this pathogen 
are numerous exotoxins such as hemolysins (Hla, Hlb, 
Hld, and Hlg), Panton-Valentine leukocidin (PVL), 
toxic shock syndrome toxin-1 (TSST-1), 
staphylococcal enterotoxins (SEs), and exfoliative toxin 
A and B (ETA and ETB) [4,5]. However, it should be 
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pointed out that most of these factors are not always 
expressed and their expression occurs in specified 
strains and under certain conditions. For instance, S. 
aureus strains that produce PVL are usually associated 
with skin and soft-tissue infections [6]. 
Pervasive resistance among clinical isolates of S. 
aureus strictly complicates management of its 
infections. In the recent decades, the global concerns 
about increasing methicillin-resistant S. aureus 
(MRSA) infections in both community and nosocomial 
settings have attracted significant attentions due to their 
therapeutic importance. MRSA strains are widespread 
in the hospital environment, and have recently caused a 
worldwide epidemic of community-acquired MRSA 
(CA-MRSA) infections [7,8]. In addition, several 
authors have reported that MRSA strains have become 
not only resistant to beta-lactam antibiotics, but they 
have also acquired additional resistance to non-beta-
lactam antibiotics, especially aminoglycosides [9]. 
Moreover, the presence of resistance gene to methicillin 
may affect toxin production [6].  
Given that the severity and rapid expansion of 
MRSA strains in the pediatric population is considered 
as an important health issue, the current study was 
conducted to characterize the virulence properties and 
factors of pediatric clinical isolates of MRSA in Tehran, 
Iran. 
 
Methodology 
Bacterial isolation and identification 
The present cross-sectional study was carried out on 
children who had any obvious staphylococcal infection, 
and also those that were asymptomatic carriers referred 
to Children's Medical Center Hospital, from September 
2014 to August 2015 in Tehran. In this study, 
asymptomatic carriers are defined as those subjects who 
had an S. aureus-positive nasal culture on the day of 
admission. Standard conventional biochemical tests for 
identification of the isolates were performed on 
colonies from primary cultures. For this purpose, all 
suspected colonies of S. aureus were examined using 
Gram staining and further identified using catalase, 
haemolysis, oxidase, coagulase, DNase, and mannitol 
fermentation tests. The isolates were stored at -70 °C in 
trypticase soy broth containing 10% glycerol for later 
analysis. 
 
Phenotypic identification of MRSA 
Methicillin resistance of S. aureus isolates was 
screened using disk diffusion test with a cefoxitin disk 
(30 µg/disk) (Mast Co., Germany) on Mueller-Hinton 
agar (Merck Co., Germany). According to the Centers 
for Disease Control and Prevention (CDC), the 
definition of CA-MRSA strains is any MRSA strain 
isolated from a patient within 48 to 72 hours of hospital 
admission, as long as the patient lacks health care-
associated MRSA risk factors like surgery, 
haemodialysis, or hospitalization during the previous 
year. Accordingly, hospital-acquired MRSA (HA-
MRSA) is defined as a MRSA strain isolated from a 
patient with established risk factors for MRSA 
infections, including recent surgery, recent 
hospitalization, residence in a long-term-care facility, 
or injecting-drug use [10,11]. 
 
Antimicrobial susceptibility test 
The antibiotic susceptibility test was performed 
using the standardized Kirby-Bauer disc-diffusion 
technique on Mueller-Hinton agar (Merck Co., 
Darmstadt, Germany). Commercially available disks of 
the antimicrobial drugs (Mast Co., Darmstadt, 
Germany), that have been used most frequently for the 
treatment of S. aureus infections, were selected and 
tested as recommended by the Clinical and Laboratory 
Standards Institute (CLSI) [12]. Accordingly, 
susceptibility of the isolates to following antibiotics: 
penicillin G (10 units/disk), 
trimethoprim/sulfamethoxazole (1.25/23.75 µg/disk), 
clindamycin (10 µg/disk), erythromycin (15 µg/disk), 
gentamicin (10 µg/disk), rifampin (5 µg/disk), 
minocycline (30 µg/disk), linezolid (30 µg/disk) and 
vancomycin (30 µg/disk) were examined. The 
susceptibility to vancomycin was confirmed through 
determining of minimum inhibitory concentration 
(MIC) using E-test (Liofilchem Co., Roseto, Italy). S. 
aureus ATCC 25923 was used as a quality control 
reference strain. In this study, a multi-drug resistant 
(MDR) S. aureus strain was considered as a single 
isolate resistant (intermediate or complete) to three or 
more unique antimicrobial classes [13]. 
 
Preparation of whole-cell DNA for PCR 
The isolates were recovered from storage via 
subculture on blood agar plates and incubated overnight 
at 37°C. Bacterial cells were suspended in 250 µl of 
phosphate-buffered saline (PBS) and then DNA 
extraction was done using whole genome DNA 
extraction kit (Cinnaclon Co., Tehran, Iran), according 
to the manufacturer's instructions. Evaluation of 
concentration and purity of extracted DNA was 
measured using Nano drop (DeNovix Inc., Wilmington, 
USA). Eluted DNA was stored at -20°C for later 
analysis.  
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Molecular assay for detection of mecA gene 
The presence of the mecA gene encoding penicillin-
binding protein 2a (PBP2a) of S. aureus isolates were 
confirmed using a PCR assay, as previously described 
by Seni J. et al. [14]. Briefly, amplification of the mecA 
gene was performed using the specific primers (forward 
primer 5'-GTAGAAATGACTGAACGTCCGATAA-
3' and Reverse primer 5'-
CCAATTCCACATTGTTTCGCTCTAA-3') yielding a 
PCR product of 307 bp.  PCR reaction was performed 
in a total volume of 25 μL containing 1X PCR buffer, 
1.5 mM MgCl2, 0.2 mM of each dNTP, 1 μL DNA 
template (3 μg/μL), 10 pmol of each primer, and 5 U 
Taq polymerase (Cinnaclon Co., Iran). Amplification of 
mecA gene was performed via the following program: 
initial denaturation at 94 °C for 2 min and 35 cycles of 
1 min at 94 °C, 1 min at 55°C and 1 min at 72 °C. The 
final extension was 5 min at 72 °C. The PCR products 
were analysed using agarose gel electrophoresis on 
1.8% NuSieve agarose gel in 1X TAE buffer at 120 V 
for 60 minutes. The expected amplicon fragments were 
extracted and purified from agarose gel using agarose 
gel DNA extraction kit (Roche Co., Mannheim, 
Germany) and then were sequenced using Bioneer 
sequencing methods (Bioneer Inc., Daejeon, South 
Korea).  
 
Molecular assay for detection of toxin genes 
The presence of the virulence genes encoding 
toxins, including PVL (luk-PV), TSST-1 (tsst-1), and 
exfoliative toxin A and B (eta and etb) were detected 
via separate monoplex PCR reactions, using specific 
primers, as shown in Table 1. PCR reactions were 
carried out in a final volume of 25 μL containing 1X 
PCR reaction buffer,10 pmol of each primer, 1 μL DNA 
template (3 μg/μL), 1.5 mM MgCl2, 0.2 mM dNTP 
mixture, and 5 U of Taq DNA polymerase (Cinnaclon, 
Tehran, Iran). The thermal cycling conditions included 
an initial denaturation step at 94 °C for 5 minutes 
followed by 30 cycles of amplification comprising of 
three steps: 2 minutes’ denaturation at 94 °C; one 
minute annealing at 55 °C for luk-PV, 46 °C for tsst-1, 
44 °C for eta and 55°C for etb; and then 1 minute 
extension at 72°C. The final extension step was at 72°C 
for 5 minutes. The PCR products were analysed using 
Tris/Borate/EDTA (TBE) buffered agarose gel (1.5%) 
electrophoresis at 120 V for 45 minutes. The expected 
amplicon fragments were purified and sequenced as 
mentioned above. 
 
Statistical analysis 
SPSS version 22.0 (IBM Corp., Armonk, USA) was 
applied for statistical analysis. Chi-square test was used 
for the comparison between the prevalence of the toxins 
according to infection site. A p value <0.05 was 
considered to be statistically significant. 
 
Results 
Patients and bacterial identification 
In the present study, 343 clinical isolates of S. 
aureus were obtained from children during an 11-
month period. The patient’s age range was from infancy 
(1 day) to 15 years old. The median age of the patients 
was 44±5 months. 
Among 343 S. aureus isolates, 100 (22.5%) were 
detected as MRSA strains by a phenotypic method. The 
distributions of mecA gene among MRSA isolates were 
100% and its sequence is available on NCBI (GenBank 
accession number KU380333). Of these, 47 isolates 
(47%) were collected from outpatient or those referred 
to emergency department and classified as CA-MRSA; 
with the remainder from different wards, including 
pediatric intensive care unit (PICU) (10%), respiratory 
(10%), surgical (10%), infection (8%), 
gastroenterology (5%), cardiology (5%), and other 
wards (5%), which were considered as HA-MRSA.  In 
total, 54%  of all MRSA isolates were obtained from 
nasal of asymptomatic carriers, and the remaining 46%  
were recovered from clinical samples of infected 
children, including wound (13%), blood (11%), sputum 
(7%), abscess (4%), ear discharges (3%), urine (2%), 
eye discharges (2%), catheter (2%), and synovial fluid 
(2%). 
 
Table 1. Primers sequences used in this study for the detection of genes encoding toxins in clinical isolates of methicillin-resistant S. aureus. 
PCR target Sequences(5’-3’) References Products size (bp) 
luk-PV 
F 
R 
CTCTAGCCGATGTCGCTCAA 
ATACCTGAGGCTCGCCACTG 
Lina G et al. (32) 433 
tsst-1 
F 
R 
TTATCGTAAGCCCTTTTGTTG 
TAAAGGTAGTTCTATTGGAGTAGG 
Designated in the present 
study. 
398 
eta 
F 
R 
GGAGAGTATGAAGTCAAAG 
GATGCTCTCTATCAAGATG 
Designated in the present 
study. 
358 
etb 
F 
R 
AAAAGGGGAATCAGCGGGAG 
TCGTTCCCCAAAGTGTCTCC 
Designated in the present 
study. 
339 
bp: base pairs; luk-PV: Panton-Valentine leucocidin gene; tsst-1: toxic shock syndrome toxin gene; eta: exfoliative toxin A gene; etb: exfoliative toxin B gene; 
F: forward primer; R: reverse primer. 
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Antibiotic resistance profile 
The antibiotics susceptibility results showed that 
the most active antibiotic against tested MRSA isolates 
were linezolid and vancomycin (100% as the 
susceptibility rate), followed by minocycline (94%), 
rifampin (88%), gentamicin (78%), 
sulfamethoxazole/trimethoprim (74%). High resistance 
rates were detected for penicillin (100%), clindamycin 
(72%), and erythromycin (59%). There was no 
significant difference in the antibiotic resistance of the 
strains according to their origin (Figure 1). In the 
present study, 73% of isolates were classified as MDR 
S. aureus strains. Moreover, our results indicated that 
69.5% of clindamycin, 74.5% of erythromycin and 73% 
of sulfamethoxazole/trimethoprim resistant strains 
were HA-MRSA isolates. 
 
Toxin profiles 
The MRSA isolates were also tested for the 
presence of PVL (luk-PV), TSST-1 (tsst-1), and 
exfoliative toxin A and B (eta and etb). The luk-PV gene 
(18%) (GenBank accession numbers KU664618 and 
KU664619) was the most prevalent virulence gene 
among the MRSA isolates, followed by tsst-1 gene 
(17%) (GenBank accession number KU380334). 
None of the MRSA isolates carried eta and etb 
genes. The percentage of isolates harboring each of the 
virulence genes is shown in Table 2. The relationships 
between antibiotic resistance and virulence genes are 
indicated in Table 3. 
 
Discussion 
In the present study, we described the drug 
resistance profiles and prevalence of luk-PV, tsst-1, eta 
and etb virulence genes among MRSA isolated from 
both carrier and infected children in Tehran, Iran. 
MRSA is one of the most common causes of 
community- and hospital-acquired localized and 
systemic infections. Approximately, all clinical isolates 
of MRSA produce a range of more than 30 various 
extracellular proteins and exoenzymes, most of which 
Table 2. Distribution of luk-PV and tsst-1 genes among methicillin-resistant S. aureus isolates according to the origin of samples. 
Origin (number) % of isolates harboring luk-PV (number) % of isolates harboring tsst-1  (number) 
Nasal swab  (n = 54) 11.1% (n = 6) 11.1% (n = 6) 
Wound (n = 13) 30.7% (n = 4) 7.7% (n = 1) 
Blood (n = 11) 36.3% (n = 4) 18.1% (n = 2) 
Sputum (n = 7) 28.6% (n = 2) 28.6% (n = 2) 
Abscess (n = 4) 0% (n = 0) 25% (n = 1) 
Ear (n = 3) 0% (n = 0) 33.3% (n = 1) 
Urine (n = 2) 0% (n = 0) 100% (n = 2) 
Eye (n = 2) 0% (n = 0) 50% (n = 1) 
Catheter (n = 2) 50% (n = 1) 50% (n = 1) 
Synovial fluid (n = 2) 0% (n = 0) 50% (n = 1) 
luk-PV: Panton-Valentine leucocidin gene; tsst-1: toxic shock syndrome toxin gene; A p-value < 0.05 was considered statistically significant. Only the 
relationship between the urine isolates and presence of the tsst-1 was significant (p value = 0.02).  
 
 
Table 3. Characterization of methicillin-resistant S. aureus isolates through the determination of antibiotic resistance profiles and prevalence 
of virulence factors. 
Resistance pattern Total number (%) 
luk-PV –positive isolates 
number (%) 
tsst-1 -positive isolates number 
(%) 
Resistant to 7-8 antibiotics 9 (9%) 1 (5.5%) 3 (17.6%) 
Resistant to 5-6 antibiotics 28 (28%) 3 (16.7%) 5 (29.5%) 
Resistant to 3- 4 antibiotics 36 (36%) 8 (44.4%) 3 (17.6%) 
Resistant to 2 antibiotics 27 (27%) 6 (33.3%) 6 (35.3%) 
luk-PV: Panton-Valentine leucocidin gene; tsst-1: toxic shock syndrome toxin gene. 
Figure 1. Prevalence of antibiotic resistance among methicillin-
resistant S. aureus isolates according to the sample origin. 
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contribute to staphylococcal pathogenesis. Of note, a 
vast majority of these factors play a direct role in 
pediatric morbidity and mortality [15]. Although our 
study revealed a relatively low incidence (22.5%) of 
MRSA among infants and children in the community 
and hospital setting, overall a higher incidence of 
MRSA infections have previously been reported in Iran 
[16-18]. However, lower distribution of MRSA (5.1%) 
was observed in the study reported by Mashouf et al. 
[19]. The observed differences can be explained by the 
fact that the other studies were conducted on all age 
groups or healthy children, while in the present study, 
we focused on pediatric patients. 
Since a large proportion of patients (47%) enrolled 
in the study were outpatients, there is reason to assume 
about half of the MRSA isolates were considered as 
CA-MRSA. CA-MRSA can have the following 
sources: patients who were discharged from hospital 
and carry MRSA, employees of nursing homes with 
MRSA, outpatients that were colonized by MRSA, and 
MRSA arising de novo in the community [20]. The first 
three sources comprise MRSA strains that spread from 
health care settings, which are considered to indicate a 
limited number of diverse genotypes, disseminate 
clonally, and express resistance to multiple 
antimicrobial agents [21]. In contrast, de novo MRSA 
isolates are assumed to evolve from methicillin-
susceptible S. aureus (MSSA) through acquisition of 
Staphylococcal Cassette Chromosome mec (SCCmec) 
elements containing a mec gene [22]. In the present 
survey, considerable prevalence of nasal MRSA 
carriage has been found among staphylococcal carriers. 
Epidemiological investigation on pediatric nasal 
carriage have evaluated small numbers of patients, but 
it can often propose that nasal carriage may be common 
in children [23,24]. Although the vast majority of 
pediatric nasal carriage of CA-MRSA are self-limited 
within a one-year period, some of them are at the risk 
of recurrent skin and soft tissue infections and therefore 
decolonization of these cases is recommended. 
Antibiotic resistance among pathogenic bacteria 
became an important public health problem in Iran, 
similar to that in the other parts of the world. Limitation 
to the use of beta lactam agents in MRSA infections 
required use of other types of antimicrobial agents for 
the treatment of these infections, so survey of 
susceptibilities of MRSA isolates for antibiotics other 
than beta lactams became very vital. Inexpensive oral 
antibiotics commonly suggested for the treatment of 
MRSA infections include tetracyclines, erythromycin, 
clindamycin, trimethoprim/sulfamethoxazole, and 
rifampin [8]. In the present survey, linezolid, 
vancomycin, minocycline, rifampin, gentamicin, and 
trimethoprim/sulfamethoxazole showed a good 
antibacterial activity against the tested MRSA isolates 
compared with the other antimicrobial agents 
mentioned. Vancomycin, for the moment, remains the 
first-line intravenous agent for severe MRSA 
infections, both CA-MRSA and HA-MRSA, and in the 
present study, we observed no resistance to 
vancomycin. The same results have been obtained in 
the studies reported by Mazloomi et al. and Ghasemian 
et al., individually [25,26]. In addition, a vast majority 
of the MRSA isolates (73%) showed a MDR pattern.  In 
accordance with our study, high rates of MDR S. aureus 
isolates were identified in the studies conducted by 
Koosha et al. and Rezaei et al. in Iran [27,28]. In 
developing countries, unreasonable administration of 
antimicrobial agents, especially beta-lactam antibiotics, 
could be responsible for the development of the MDR 
bacteria. In light of these findings, Iranian physicians 
and clinicians are more concerned than ever with the 
increasing spread of clinical isolates of MDR S. aureus. 
In the present study, it was found that less than one-
fifth of MRSA isolates, obtained from pediatric 
patients, harbored luk-PV (18%) and tsst-1 (17%) 
virulence genes, whereas no isolate had eta or etb. 
However, high detection frequencies of eta (11.3%) and 
etb (9%) were reported in Sabouni study [29] and 
almost the same incidence was reported in other studies 
[6,30,31]. This may be sensible because none of the 
MRSA strains in the current survey was isolated from 
children with skin diseases including staphylococcal 
scalded skin syndrome (SSSS), impetigo, or blisters. 
Generally, PVL has been associated with S. aureus soft 
tissue infections and severe necrotizing pneumonia, 
with the mortality rate for the latter being reported to be 
about 75% [32]. In an investigation by Lina et al., it was 
indicated that 50%-93% of S. aureus isolates 
responsible for cellulites, furunculosis, or cutaneous 
abscess and 85% of those responsible for community-
acquired pneumonia harbored the luk-PV gene, as 
compared with none of those causing diseases, such as 
urinary tract infection, infective endocarditis, 
enterocolitis, nosocomial pneumonia, or toxic-shock 
syndrome [33]. In the present study, luk-PV positive 
isolates were strongly associated with blood, 
respiratory secretion and wound cultures. The luk-PV 
gene was found in 5% of blood and 3% of pharynx 
samples. Overall, the prevalence of the luk-PV gene has 
been estimated to be 2-35% among MRSA isolates in 
various types of nosocomial infections [34,35]. In the 
study by Dormanesh et al., high luk-PV gene 
distribution (63.5%) among MRSA isolated from 
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pediatric nosocomial infections was found [36]. Studies 
carried out in different countries have shown the same 
distribution, for instance, Esan et al. in Nigeria and 
Shallcross et al. in the United Kingdom reported that 16 
% and 11.3% of MRSA isolates harbored luk-PV gene, 
respectively. Although the association between luk-PV 
gene and CA-MRSA strains is a subject of debate, to 
date, PVL has emerged as a significant virulence factor 
of CA-MRSA isolates making it a putative marker of 
these strains [37]. In a study conducted by D’Souza et 
al. in Mumbai between 2006 and 2009, it was found that 
none of the HA-MRSA isolates carried the luk-PV gene 
[38]. In contrast, in the present study, only 25% of luk-
PV positive strains were isolated from outpatients and 
others were isolated from patients who were 
hospitalized for more than 48 hours. Thus, the 
association of CA-MRSA isolates and luk-PV gene 
could not be verified in the current study. The present 
study also showed that the prevalence of tsst-1 genes is 
high in eye and urine samples. 
 
Conclusion 
To the extent of our knowledge, the present study is 
one of the few studies that demonstrates the prevalence 
of virulent determinants of MRSA isolated from 
pediatric patients. In the current study, MRSA isolates 
were typically associated with both hospital and 
community acquired infections. In addition, the results 
show that the virulence gene content of MRSA isolated 
from pediatric patients varies widely. Therefore, 
efficient and accurate epidemiological typing methods 
such as pulsed-field gel electrophoresis (PFGE) and spa 
typing are suggested for surveillance and limiting the 
occurrence and spread of epidemic clones within and 
between hospitals and to community settings. 
Moreover, to prevent the spread of MRSA strains in 
health care settings, the decision was made to 
implement MRSA measures derived from those in use 
in many hospitals. The measures involved the frequent 
usage of nasal mupirocin and chlorhexidine showers for 
patients who are at risk for MRSA transmission or 
infection. 
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